189 related articles for article (PubMed ID: 8149982)
1. Involvement of delta 1-opioid receptor antagonism in the antitussive effect of delta-opioid receptor antagonists.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1994 Jan; 251(2-3):291-4. PubMed ID: 8149982
[TBL] [Abstract][Full Text] [Related]
2. Antitussive effects of naltrindole, a selective delta-opioid receptor antagonist, in mice and rats.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1993 Nov; 249(2):161-5. PubMed ID: 8287897
[TBL] [Abstract][Full Text] [Related]
3. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
Sofuoglu M; Portoghese PS; Takemori AE
Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of mu-opioid receptor-mediated antitussive activity by delta-opioid receptor agonists in mice.
Kamei J; Iwamoto Y; Suzuki T; Nagase H; Misawa M; Kasuya Y
Eur J Pharmacol; 1993 Mar; 234(1):117-20. PubMed ID: 8386091
[TBL] [Abstract][Full Text] [Related]
5. Blockade of delta-opioid receptors prevents morphine-induced place preference in mice.
Suzuki T; Yoshiike M; Mizoguchi H; Kamei J; Misawa M; Nagase H
Jpn J Pharmacol; 1994 Sep; 66(1):131-7. PubMed ID: 7861658
[TBL] [Abstract][Full Text] [Related]
6. Spinal delta opioid receptor subtype activity of 6-monoacetylmorphine in Swiss Webster mice.
Rady JJ; Baemmert D; Takemori AE; Portoghese PS; Fujimoto JM
Pharmacol Biochem Behav; 1997 Feb; 56(2):243-9. PubMed ID: 9050081
[TBL] [Abstract][Full Text] [Related]
7. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
8. Antitussive effect of dihydroetorphine in mice.
Kamei J; Iwamoto Y; Suzuki T; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1994 Aug; 260(2-3):257-9. PubMed ID: 7988653
[TBL] [Abstract][Full Text] [Related]
9. Role of opioid receptors (mu, delta 1, delta 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat.
Wang XM; Yan JQ; Zhang KM; Mokha SS
Brain Res; 1996 Nov; 739(1-2):235-43. PubMed ID: 8955943
[TBL] [Abstract][Full Text] [Related]
10. Antitussive effect of [Met5]enkephalin-Arg6-Phe7 in mice.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Eur J Pharmacol; 1994 Mar; 253(3):293-6. PubMed ID: 8200424
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic administration of 7-benzylidene-7-dehydronaltrexone and naltriben on the antinociceptive actions of delta 1- and delta 2-opioid receptor agonists.
Bhargava HN; Zhao GM; House RV; Thomas PT
Eur J Pharmacol; 1996 Sep; 311(2-3):127-32. PubMed ID: 8891592
[TBL] [Abstract][Full Text] [Related]
12. The antitussive effects of endomorphin-1 and endomorphin-2 in mice.
Kamei J; Morita K; Saitoh A; Nagase H
Eur J Pharmacol; 2003 Apr; 467(1-3):219-22. PubMed ID: 12706478
[TBL] [Abstract][Full Text] [Related]
13. Modulation of mu-mediated antitussive activity in rats by a delta agonist.
Kamei J; Tanihara H; Kasuya Y
Eur J Pharmacol; 1991 Oct; 203(1):153-6. PubMed ID: 1665789
[TBL] [Abstract][Full Text] [Related]
14. A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone.
Portoghese PS; Sultana M; Nagase H; Takemori AE
Eur J Pharmacol; 1992 Jul; 218(1):195-6. PubMed ID: 1327826
[TBL] [Abstract][Full Text] [Related]
15. Streptozotocin-induced diabetes selectively enhances antinociception mediated by delta 1- but not delta 2-opioid receptors.
Kamei J; Iwamoto Y; Misawa M; Nagase H; Kasuya Y
Life Sci; 1994; 55(6):PL121-6. PubMed ID: 8035657
[TBL] [Abstract][Full Text] [Related]
16. Delta antagonist and kappa agonist activity of Naltriben: evidence for differential kappa interaction with the delta 1 and delta 2 opioid receptor subtypes.
Stewart PE; Holper EM; Hammond DL
Life Sci; 1994; 55(4):PL79-84. PubMed ID: 8028443
[TBL] [Abstract][Full Text] [Related]
17. Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice.
Suzuki T; Tsuji M; Mori T; Misawa M; Endoh T; Nagase H
Life Sci; 1995; 57(2):155-68. PubMed ID: 7603296
[TBL] [Abstract][Full Text] [Related]
18. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
19. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
20. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat.
Thorat SN; Hammond DL
J Pharmacol Exp Ther; 1997 Dec; 283(3):1185-92. PubMed ID: 9399992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
